Alexander Seifalian
Overview
Explore the profile of Alexander Seifalian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khayatan D, Barzegar P, Fatima A, Sattar T, Zahid A, Batool S, et al.
J Transl Med
. 2025 Feb;
23(1):154.
PMID: 39905476
Lung disorders rank among the leading causes of mortality worldwide, presenting a critical challenge in healthcare. The underlying limited regenerative capacity of the lung makes this an unmet clinical need,...
2.
Hajmohammadi Z, Bagher Z, Taghizadeh-Hesary F, Khodadadi M, Masror N, Asghari A, et al.
Eur J Pharm Biopharm
. 2024 Jul;
202:114393.
PMID: 38992481
Sensorineural hearing loss (SNHL), often stemming from reactive oxygen species (ROS) generation due to various factors such as ototoxic drugs, acoustic trauma, and aging, remains a significant health concern. Oxidative...
3.
Memarian P, Bagher Z, Asghari S, Aleemardani M, Seifalian A
Nanoscale
. 2024 Jun;
16(27):12793-12819.
PMID: 38919053
Cardiovascular diseases (CDs) are the foremost cause of death worldwide. Several promising therapeutic methods have been developed for this approach, including pharmacological, surgical intervention, cell therapy, or biomaterial implantation since...
4.
Hemmati J, Chiani M, Chegini Z, Seifalian A, Arabestani M
Sci Rep
. 2024 Jun;
14(1):13362.
PMID: 38862754
The Increase in infections caused by resistant strains of Pseudomonas aeruginosa poses a formidable challenge to global healthcare systems. P. aeruginosa is capable of causing severe human infections across diverse...
5.
Gharatape A, Sadeghi-Abandansari H, Seifalian A, Faridi-Majidi R, Basiri M
J Mater Chem B
. 2024 Mar;
12(14):3356-3375.
PMID: 38505950
Clinical advances in genetically modified immune cell therapies, such as chimeric antigen receptor T cell therapies, have raised hope for cancer treatment. The majority of these biotechnologies are based on...
6.
Dehbashi S, Tahmasebi H, Alikhani M, Vidal J, Seifalian A, Arabestani M
J Infect Public Health
. 2024 Jan;
17(2):329-338.
PMID: 38194764
Background: Because of the rise in antibiotic resistance and the control of pathogenicity, polymicrobial bacterial biofilms exacerbate wound infections. Since bacterial quorum sensing (QS) signals can dysregulate biofilm development, they...
7.
Hasanzadeh E, Seifalian A, Mellati A, Saremi J, Asadpour S, Enderami S, et al.
Mater Today Bio
. 2023 Apr;
20:100614.
PMID: 37008830
Repairing central nervous system (CNS) is difficult due to the inability of neurons to recover after damage. A clinically acceptable treatment to promote CNS functional recovery and regeneration is currently...
8.
Babaluei M, Mottaghitalab F, Seifalian A, Farokhi M
Int J Biol Macromol
. 2023 Mar;
236:124005.
PMID: 36907296
Burn injuries are a major global problem, with a high risk of infection and mortality. This study aimed to develop an injectable hydrogel for wound dressings, composed of sodium carboxymethylcellulose/polyacrylamide/polydopamine...
9.
Will carbon nanotube/nanofiber bring new hope for the treatment of heart damage? A systematic review
Tashakori-Miyanroudi M, Janzadeh A, Seifalian A, Aboutaleb N, Azizi Y, Ramezani F
Nanomedicine (Lond)
. 2023 Mar;
17(29):2189-2205.
PMID: 36896892
Despite scientific advances, the number of cardiovascular patients is increasing worldwide. To protect damaged cardiomyocytes from further harm, novel and safer approaches are needed to help regeneration and prevent fibrosis....
10.
Taghipour Y, Zarebkohan A, Salehi R, Rahimi F, Torchilin V, Hamblin M, et al.
J Control Release
. 2022 Jul;
349:67-96.
PMID: 35779656
The key issue in the treatment of solid tumors is the lack of efficient strategies for the targeted delivery and accumulation of therapeutic cargoes in the tumor microenvironment (TME). Targeting...